OpenURL Connection Search

Select item for more details and to access through your institution.

Incident microalbuminuria and complement factor mannan-binding lectin-associated protein 19 in people with newly diagnosed type 1 diabetes.
Published in:
2017
By:
- Østergaard, J.A.;
- Thiel, S.;
- Hoffmann‐Petersen, I.T.;
- Hovind, P.;
- Parving, H.‐H.;
- Tarnow, L.;
- Rossing, P.;
- Hansen, T.K.
Publication type:
journal article
Optimal dose of lisinopril for renoprotection in type 1 diabetic patients with diabetic nephropathy: a randomised crossover trial.
Published in:
Diabetologia, 2009, v. 52, n. 1, p. 46, doi. 10.1007/s00125-008-1184-8
By:
- Schjoedt, K.;
- Astrup, A.;
- Persson, F.;
- Frandsen, E.;
- Boomsma, F.;
- Rossing, K.;
- Tarnow, L.;
- Rossing, P.;
- Parving, H.-H.
Publication type:
Article
Plasma osteoprotegerin levels predict cardiovascular and all-cause mortality and deterioration of kidney function in type 1 diabetic patients with nephropathy.
Published in:
Diabetologia, 2008, v. 51, n. 11, p. 2100, doi. 10.1007/s00125-008-1123-8
By:
- Jorsal, A.;
- Tarnow, L.;
- Flyvbjerg, A.;
- Parving, H.-H.;
- Rossing, P.;
- Rasmussen, L.
Publication type:
Article
Long-term prevention of diabetic nephropathy: an audit.
Published in:
Diabetologia, 2008, v. 51, n. 6, p. 956, doi. 10.1007/s00125-008-0990-3
By:
- Schjoedt, K.;
- Hansen, H.;
- Tarnow, L.;
- Rossing, P.;
- Parving, H.-H.
Publication type:
Article
Increased renal gene transcription of protein kinase C-β in human diabetic nephropathy: relationship to long-term glycaemic control.
Published in:
Diabetologia, 2008, v. 51, n. 4, p. 668, doi. 10.1007/s00125-008-0927-x
By:
- Langham, R.;
- Kelly, D.;
- Gow, R.;
- Zhang, Y.;
- Cox, A.;
- Qi, W.;
- Thai, K.;
- Pollock, C.;
- Christensen, P.;
- Parving, H.-H.;
- Gilbert, R.
Publication type:
Article
Plasma N-terminal pro-B-type natriuretic peptide and mortality in type 2 diabetes.
Published in:
Diabetologia, 2006, v. 49, n. 10, p. 2256, doi. 10.1007/s00125-006-0359-4
By:
- Tarnow, L.;
- Gall, M.-A.;
- Hansen, B. V.;
- Hovind, P.;
- Parving, H.-H.
Publication type:
Article
Anaemia in diabetes: is there a rationale to TREAT?
Published in:
2006
By:
- Thomas, M. C.;
- Cooper, M. E.;
- Rossing, K.;
- Parving, H. H.
Publication type:
Letter
Remission of nephrotic-range albuminuria reduces risk of end-stage renal disease and improves survival in type 2 diabetic patients.
Published in:
Diabetologia, 2005, v. 48, n. 11, p. 2241, doi. 10.1007/s00125-005-1937-6
By:
- Rossing, K.;
- Christensen, P. K.;
- Hovind, P.;
- Parving, H.-H.
Publication type:
Article
Adverse effects of left ventricular hypertrophy in the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study.
Published in:
Diabetologia, 2005, v. 48, n. 10, p. 1980, doi. 10.1007/s00125-005-1893-1
By:
- Boner, G.;
- Cooper, M. E.;
- McCarroll, K.;
- Brenner, B. M.;
- de Zeeuw, D.;
- Kowey, P. P.;
- Shahinfar, S.;
- Dickson, T.;
- Crow, R. S.;
- Parving, H.-H.
Publication type:
Article
Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications.
Published in:
Diabetologia, 2005, v. 48, n. 9, p. 1911, doi. 10.1007/s00125-005-1850-z
By:
- Frystyk, J.;
- Tarnow, L.;
- Krarup Hansen, T.;
- Parving, H.-H.;
- Flyvbjerg, A.
Publication type:
Article
The prevalence of coeliac disease in adult Danish patients with type 1 diabetes with and without nephropathy.
Published in:
2005
By:
- Skovbjerg, H.;
- Tarnow, L.;
- Locht, H.;
- Parving, H.-H.
Publication type:
Letter
Aldosterone escape during blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate.
Published in:
Diabetologia, 2004, v. 47, n. 11, p. 1936, doi. 10.1007/s00125-004-1542-0
By:
- Schjoedt, K.J.;
- Andersen, S.;
- Rossing, P.;
- Tarnow, L.;
- Parving, H.-H.
Publication type:
Article
Total plasma homocysteine is associated with hypertension in Type I diabetic patients S. Neugebauer et al.: Homocysteine as determinant for hypertension.
Published in:
Diabetologia, 2002, v. 45, n. 9, p. 1315, doi. 10.1007/s00125-002-0908-4
By:
- Neugebauer, S.;
- Tarnow, L.;
- Stehouwer, C.;
- Teerlink, T.;
- Baba, T.;
- Watanabe, T.;
- Parving, H.-H.
Publication type:
Article
Pregnancy and progression of diabetic nephropathy.
Published in:
Diabetologia, 2002, v. 45, n. 1, p. 36, doi. 10.1007/s125-002-8242-4
By:
- Rossing, K.;
- Jacobsen, P.;
- Hommel, E.;
- Mathiesen, E.;
- Svenningsen, A.;
- Rossing, P.;
- Parving, H.-H.
Publication type:
Article
Lack of synergism between long-term poor glycaemic control and three gene polymorphisms of the renin angiotensin system on risk of developing diabetic nephropathy in Type I diabetic patients.
Published in:
Diabetologia, 2000, v. 43, n. 6, p. 794, doi. 10.1007/s001250051377
By:
- Tarnow, L.;
- Kjeld, T.;
- Knudsen, E.;
- Major-Pedersen, A.;
- Parving, H. -H.
Publication type:
Article
Effect of adjunct metformin treatment on levels of plasma lipids in patients with type 1 diabetes.
Published in:
Diabetes, Obesity & Metabolism, 2009, v. 11, n. 10, p. 966, doi. 10.1111/j.1463-1326.2009.01079.x
By:
- Lund, S. S.;
- Tarnow, L.;
- Astrup, A. S.;
- Hovind, P.;
- Jacobsen, P. K.;
- Alibegovic, A. C.;
- Parving, I.;
- Pietraszek, L.;
- Frandsen, M.;
- Rossing, P.;
- Parving, H.-H.;
- Vaag, A. A.
Publication type:
Article
Targeting hyperglycaemia with either metformin or repaglinide in non-obese patients with type 2 diabetes: results from a randomized crossover trial.
Published in:
Diabetes, Obesity & Metabolism, 2007, v. 9, n. 3, p. 394, doi. 10.1111/j.1463-1326.2007.00713.x
By:
- Lund, S. S.;
- Tarnow, L.;
- Stehouwer, C. D. A.;
- Schalkwijk, C. G.;
- Frandsen, M.;
- Smidt, U. M.;
- Pedersen, O.;
- Parving, H.-H.;
- Vaag, A.
Publication type:
Article
Higher plasma high-mobility group box 1 levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12 year follow-up study.
Published in:
Diabetologia, 2012, v. 55, n. 9, p. 2489, doi. 10.1007/s00125-012-2622-1
By:
- Nin, J.;
- Ferreira, I.;
- Schalkwijk, C.;
- Jorsal, A.;
- Prins, M.;
- Parving, H.-H.;
- Tarnow, L.;
- Rossing, P.;
- Stehouwer, C.
Publication type:
Article
SNP in the genome-wide association study hotspot on chromosome 9p21 confers susceptibility to diabetic nephropathy in type 1 diabetes.
Published in:
Diabetologia, 2012, v. 55, n. 9, p. 2386, doi. 10.1007/s00125-012-2587-0
By:
- Fagerholm, E.;
- Ahlqvist, E.;
- Forsblom, C.;
- Sandholm, N.;
- Syreeni, A.;
- Parkkonen, M.;
- McKnight, A.;
- Tarnow, L.;
- Maxwell, A.;
- Parving, H.-H.;
- Groop, L.;
- Groop, P.-H.
Publication type:
Article
Erratum to: Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial.
Published in:
2011
By:
- Miao, Y.;
- Dobre, D.;
- Lambers Heerspink, H.;
- Brenner, B.;
- Cooper, M.;
- Parving, H.-H.;
- Shahinfar, S.;
- Grobbee, D.;
- Zeeuw, D.
Publication type:
Correction Notice
Exposure to candesartan during the first trimester of pregnancy in type 1 diabetes: experience from the placebo-controlled diabetic retinopathy candesartan trials.
Published in:
Diabetologia, 2011, v. 54, n. 6, p. 1298, doi. 10.1007/s00125-010-2040-1
By:
- Porta, M.;
- Hainer, J.;
- Jansson, S.-O.;
- Malm, A.;
- Bilous, R.;
- Chaturvedi, N.;
- Fuller, J.;
- Klein, R.;
- Orchard, T.;
- Parving, H.-H.;
- Sjølie, A.-K.
Publication type:
Article
Increased serum potassium affects renal outcomes: a post hoc analysis of the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial.
Published in:
Diabetologia, 2011, v. 54, n. 1, p. 44, doi. 10.1007/s00125-010-1922-6
By:
- Miao, Y.;
- Dobre, D.;
- Lambers Heerspink, H.;
- Brenner, B.;
- Cooper, M.;
- Parving, H-H.;
- Shahinfar, S.;
- Grobbee, D.;
- Zeeuw, D.
Publication type:
Article
Multifactorial treatment increases endothelial progenitor cells in patients with type 2 diabetes.
Published in:
Diabetologia, 2010, v. 53, n. 10, p. 2129, doi. 10.1007/s00125-010-1843-4
By:
- Reinhard, H.;
- Jacobsen, P.;
- Lajer, M.;
- Pedersen, N.;
- Billestrup, N.;
- Mandrup-Poulsen, T.;
- Parving, H.-H.;
- Rossing, P.
Publication type:
Article
Optimal antiproteinuric dose of aliskiren in type 2 diabetes mellitus: a randomised crossover trial.
Published in:
Diabetologia, 2010, v. 53, n. 8, p. 1576, doi. 10.1007/s00125-010-1789-6
By:
- Persson, F.;
- Rossing, P.;
- Reinhard, H.;
- Juhl, T.;
- Stehouwer, C.;
- Schalkwijk, C.;
- Danser, A.;
- Boomsma, F.;
- Frandsen, E.;
- Parving, H.-H.
Publication type:
Article
Telomere length predicts all-cause mortality in patients with type 1 diabetes.
Published in:
Diabetologia, 2010, v. 53, n. 1, p. 45, doi. 10.1007/s00125-009-1542-1
By:
- Astrup, A.;
- Tarnow, L.;
- Jorsal, A.;
- Lajer, M.;
- Nzietchueng, R.;
- Benetos, A.;
- Rossing, P.;
- Parving, H.-H.
Publication type:
Article
Irbesartan treatment does not influence plasma levels of the dicarbonyls methylglyoxal, glyoxal and 3‐deoxyglucosone in participants with type 2 diabetes and microalbuminuria: An IRMA2 sub‐study.
Published in:
Diabetic Medicine, 2021, v. 38, n. 9, p. 1, doi. 10.1111/dme.14405
By:
- Piazza, M.;
- Hanssen, N. M. J.;
- Persson, F.;
- Scheijen, J. L.;
- van de Waarenburg, M. P. H.;
- van Greevenbroek, M. M. J.;
- Rossing, P.;
- Hovind, P.;
- Stehouwer, C. D. A.;
- Parving, H‐H.;
- Schalkwijk, C. G.
Publication type:
Article
Comparing effects of insulin analogues and human insulin on nocturnal glycaemia in hypoglycaemia-prone people with Type 1 diabetes.
Published in:
Diabetic Medicine, 2017, v. 34, n. 5, p. 625, doi. 10.1111/dme.13317
By:
- Kristensen, P. L.;
- Tarnow, L.;
- Bay, C.;
- Nørgaard, K.;
- Jensen, T.;
- Parving, H.‐H.;
- Perrild, H.;
- Beck‐Nielsen, H.;
- Christiansen, J. S.;
- Thorsteinsson, B.;
- Pedersen‐Bjergaard, U.
Publication type:
Article
Urinary sulphate excretion and progression of diabetic nephropathy in Type 1 diabetes.
Published in:
Diabetic Medicine, 2013, v. 30, n. 5, p. 563, doi. 10.1111/dme.12131
By:
- Andrésdóttir, G.;
- Bakker, S. J. L.;
- Hansen, H. P.;
- Parving, H.‐H.;
- Rossing, P.
Publication type:
Article
Arterial stiffness and endothelial dysfunction independently and synergistically predict cardiovascular and renal outcome in patients with type 1 diabetes.
Published in:
Diabetic Medicine, 2012, v. 29, n. 8, p. 990, doi. 10.1111/j.1464-5491.2012.03633.x
By:
- Theilade, S.;
- Lajer, M.;
- Jorsal, A.;
- Tarnow, L.;
- Parving, H.-H.;
- Rossing, P.
Publication type:
Article
Spironolactone diminishes urinary albumin excretion in patients with type 1 diabetes and microalbuminuria: a randomized placebo-controlled crossover study.
Published in:
Diabetic Medicine, 2012, v. 29, n. 8, p. e184, doi. 10.1111/j.1464-5491.2012.03585.x
By:
- Nielsen, S. E.;
- Persson, F.;
- Frandsen, E.;
- Sugaya, T.;
- Hess, G.;
- Zdunek, D.;
- Shjoedt, K. J.;
- Parving, H-H.;
- Rossing, P.
Publication type:
Article
Evaluation of placental growth factor and soluble Fms-like tyrosine kinase 1 as predictors of all-cause and cardiovascular mortality in patients with Type 1 diabetes with and without diabetic nephropathy.
Published in:
Diabetic Medicine, 2012, v. 29, n. 3, p. 337, doi. 10.1111/j.1464-5491.2011.03482.x
By:
- Theilade, S.;
- Lajer, M.;
- Jorsal, A.;
- Tarnow, L.;
- Parving, H.-H.;
- Rossing, P.
Publication type:
Article
Retinal microaneurysm count predicts progression and regression of diabetic retinopathy. Post-hoc results from the DIRECT Programme.
Published in:
Diabetic Medicine, 2011, v. 28, n. 3, p. 345, doi. 10.1111/j.1464-5491.2010.03210.x
By:
- Sjølie, A. K.;
- Klein, R.;
- Porta, M.;
- Orchard, T.;
- Fuller, J.;
- Parving, H. H.;
- Bilous, R.;
- Aldington, S.;
- Chaturvedi, N.
Publication type:
Article
Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril.
Published in:
Diabetic Medicine, 2010, v. 27, n. 10, p. 1144, doi. 10.1111/j.1464-5491.2010.03083.x
By:
- Nielsen, S. E.;
- Schjoedt, K. J.;
- Astrup, A. S.;
- Tarnow, L.;
- Lajer, M.;
- Hansen, P. R.;
- Parving, H.-H.;
- Rossing, P.
Publication type:
Article
Pregnancy-associated plasma protein A in a large cohort of Type 1 diabetic patients with and without diabetic nephropathy—a prospective follow-up study.
Published in:
Diabetic Medicine, 2007, v. 24, n. 12, p. 1381, doi. 10.1111/j.1464-5491.2007.02283.x
By:
- Astrup, A. S.;
- Tarnow, L.;
- Christiansen, M.;
- Hansen, P. R.;
- Parving, H.-H.;
- Rossing, P.
Publication type:
Article
Endothelial dysfunction and low-grade inflammation and the progression of retinopathy in Type 2 diabetes.
Published in:
Diabetic Medicine, 2007, v. 24, n. 9, p. 969, doi. 10.1111/j.1464-5491.2007.02217.x
By:
- Spijkerman, A. M. W.;
- Gall, M.-A.;
- Tarnow, L.;
- Twisk, J. W. R.;
- Lauritzen, E.;
- Lund-Andersen, H.;
- Emeis, J.;
- Parving, H.-H.;
- Stehouwer, C. D. A.
Publication type:
Article
CYP2C9 variant modifies blood pressure-lowering response to losartan in Type 1 diabetic patients with nephropathy.
Published in:
2007
By:
- Lajer, M.;
- Tarnow, L.;
- Andersen, S.;
- Parving, H.-H.
Publication type:
Letter
Aldosterone synthase (CYP11B2) −344T/C polymorphism is not associated with the initiation and progression of diabetic nephropathy in Caucasian Type 1 diabetic patients.
Published in:
Diabetic Medicine, 2006, v. 23, n. 6, p. 675, doi. 10.1111/j.1464-5491.2006.01871.x
By:
- Lajer, M.;
- Schjoedt, K. J.;
- Jacobsen, P.;
- Tarnow, L.;
- Parving, H.-H.
Publication type:
Article
Association of aldose reductase gene Z+2 polymorphism with reduced susceptibility to diabetic nephropathy in Caucasian Type 1 diabetic patients.
Published in:
Diabetic Medicine, 2004, v. 21, n. 8, p. 867, doi. 10.1111/j.1464-5491.2004.01259.x
By:
- Lajer, M.;
- Tarnow, L.;
- Fleckner, J.;
- Hansen, B. V.;
- Edwards, D. G.;
- Parving, H-H.;
- Boel, E.
Publication type:
Article
Is a reduction in albuminuria associated with renal and cardiovascular protection? A post hoc analysis of the ALTITUDE trial.
Published in:
Diabetes, Obesity & Metabolism, 2016, v. 18, n. 2, p. 169, doi. 10.1111/dom.12600
By:
- Heerspink, H. J. L.;
- Ninomiya, T.;
- Persson, F.;
- Brenner, B. M.;
- Brunel, P.;
- Chaturvedi, N.;
- Desai, A. S.;
- Haffner, S. M.;
- Mcmurray, J. J. V.;
- Solomon, S. D.;
- Pfeffer, M. A.;
- Parving, H.‐H.;
- de Zeeuw, D.
Publication type:
Article
Early renin-angiotensin system intervention is more beneficial than late intervention in delaying end-stage renal disease in patients with type 2 diabetes.
Published in:
Diabetes, Obesity & Metabolism, 2016, v. 18, n. 1, p. 64, doi. 10.1111/dom.12583
By:
- Schievink, B.;
- Kröpelin, T.;
- Mulder, S.;
- Parving, H.‐H.;
- Remuzzi, G.;
- Dwyer, J.;
- Vemer, P.;
- de Zeeuw, D.;
- Lambers Heerspink, H. J.
Publication type:
Article
The effect of metabolic control on hemodynamics in short-term insulin-dependent diabetic patients.
Published in:
1985
By:
- Mathiesen, E. R.;
- Hilsted, J.;
- Feldt-Rasmussen, B.;
- Bonde-Petersen, F.;
- Christensen, N. J.;
- Parving, H.-H.
Publication type:
journal article
Intravenous insulin has no effect on transcapillary escape rate of albumin and on plasma volume in short-term juvenile diabetics.
Published in:
1979
By:
- Parving, H.-H.;
- Noer, I.;
- Deckert, T.;
- Lassen, N. A.
Publication type:
journal article
The association between metabolic syndrome, microalbuminuria and impaired renal function in the general population: impact on cardiovascular disease and mortality.
Published in:
Journal of Internal Medicine, 2007, v. 262, n. 4, p. 470, doi. 10.1111/j.1365-2796.2007.01839.x
By:
- Klausen, K. P.;
- Parving, H.-H.;
- Scharling, H.;
- Jensen, J. S.
Publication type:
Article
Effect of short-term hyperglycaemia on haemodynamics in type 1 diabetic patients.
Published in:
Journal of Internal Medicine, 2003, v. 254, n. 5, p. 464, doi. 10.1046/j.1365-2796.2003.01216.x
By:
- Jacobsen, P.;
- Rossing, K.;
- Hansen, B.V.;
- Bie, P.;
- Vaag, A.;
- Parving, H.-H.
Publication type:
Article
Birth weight--a risk factor for progression in diabetic nephropathy?
Published in:
2003
By:
- Jacobsen, P.;
- Rossing, P.;
- Tarnow, L.;
- Hovind, P.;
- Parving, H-H.
Publication type:
journal article
ACID GLYCOSAMINOGLYCANS IN MYXOEDEMA.
Published in:
Clinical Endocrinology, 1982, v. 16, n. 2, p. 207, doi. 10.1111/j.1365-2265.1982.tb03166.x
By:
- PARVING, H-H.;
- HELIN, G.;
- GARBARSCH, C.;
- JOHANSEN, A.A.;
- JENSEN, B. A.;
- HELIN, P.;
- LUND, P.;
- LYNGSØE, J.
Publication type:
Article
Plasma matrix metalloproteinases are associated with incident cardiovascular disease and all-cause mortality in patients with type 1 diabetes: a 12-year follow-up study.
Published in:
Cardiovascular Diabetology, 2017, v. 16, p. 1, doi. 10.1186/s12933-017-0539-1
By:
- Peeters, S. A.;
- Engelen, L.;
- Buijs, J.;
- Jorsal, A.;
- Parving, H.-H.;
- Tarnow, L.;
- Rossing, P.;
- Schalkwijk, C. G.;
- Stehouwer, C. D. A.
Publication type:
Article
Diabetes and end stage renal disease.
Published in:
American Journal of Hypertension, 2000, v. 13, p. 322A, doi. 10.1016/S0895-7061(00)00864-5
By:
- Parving*, H.-H.
Publication type:
Article
Double-blind, randomised study of the effect of combined treatment with vitamin C and E on albuminuria in Type 2 diabetic patients.
Published in:
Diabetic Medicine, 2001, v. 18, n. 9, p. 756, doi. 10.1046/j.0742-3071.2001.00574.x
By:
- Gæde, P.;
- Poulsen, H. E.;
- Parving, H.-H.;
- Pedersen, O.
Publication type:
Article
Prolonged QTc interval predicts mortality in patients with Type 1 diabetes mellitus.
Published in:
Diabetic Medicine, 2001, v. 18, n. 3, p. 199, doi. 10.1046/j.1464-5491.2001.00446.x
By:
- Rossing, P.;
- Breum, L.;
- Major-Pedersen, A.;
- Sato, A.;
- Windling, H.;
- Pietersen, A.;
- Kastrup, J.;
- Parving, H.-H.
Publication type:
Article

Found: 110